Current studies indicate that excessive activation of ErbB tyrosine kinase family was associated with anoikis resistance in breast cancer or prostate cancers (24, 25), but the association of ErbB and anoikis has not yet been explored in HCC. The gene discussed is EGFR; the disease is prostate cancer.